View of Association of Semaglutide Therapy with Weight Loss and Cardiovascular and Heart Failure Risk in Patients with Type 2 Diabetes Mellitus

Return to Article Details Association of Semaglutide Therapy with Weight Loss and Cardiovascular and Heart Failure Risk in Patients with Type 2 Diabetes Mellitus Download Download PDF